1 Study Coverage 1.1 Immuno-Oncology Treatment Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Introduction 1.2 Global Immuno-Oncology Treatment Outlook 2017 VS 2022 VS 2028 1.2.1 Global Immuno-Oncology Treatment Market Size for the Year 2017-2028 1.2.2 Global Immuno-Oncology Treatment Market Size for the Year 2017-2028 1.3 Immuno-Oncology Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.3.1 The Market Share of United States Immuno-Oncology Treatment in Global, 2017 VS 2022 VS 2028 1.3.2 The Growth Rate of Immuno-Oncology Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4 Immuno-Oncology Treatment Market Dynamics 1.4.1 Immuno-Oncology Treatment Industry Trends 1.4.2 Immuno-Oncology Treatment Market Drivers 1.4.3 Immuno-Oncology Treatment Market Challenges 1.4.4 Immuno-Oncology Treatment Market Restraints 1.5 Study Objectives 1.6 Years Considered 2 Immuno-Oncology Treatment by Type 2.1 Immuno-Oncology Treatment Market Segment by Type 2.1.1 Immune Checkpoint Inhibitors 2.1.2 Monoclonal Antibodies 2.1.3 Cytokine-Based Immunotherapy 2.1.4 Cancer Vaccines 2.1.5 CAR-T Cell Therapy 2.2 Global Immuno-Oncology Treatment Market Size by Type (2017, 2022 & 2028) 2.3 Global Immuno-Oncology Treatment Market Size by Type (2017-2028) 2.4 United States Immuno-Oncology Treatment Market Size by Type (2017, 2022 & 2028) 2.5 United States Immuno-Oncology Treatment Market Size by Type (2017-2028) 3 Immuno-Oncology Treatment by Application 3.1 Immuno-Oncology Treatment Market Segment by Application 3.1.1 Hospitals 3.1.2 Ambulatory Surgical Center 3.1.3 Others 3.2 Global Immuno-Oncology Treatment Market Size by Application (2017, 2022 & 2028) 3.3 Global Immuno-Oncology Treatment Market Size by Application (2017-2028) 3.4 United States Immuno-Oncology Treatment Market Size by Application (2017, 2022 & 2028) 3.5 United States Immuno-Oncology Treatment Market Size by Application (2017-2028) 4 Global Immuno-Oncology Treatment Competitor Landscape by Company 4.1 Global Immuno-Oncology Treatment Market Size by Company 4.1.1 Top Global Immuno-Oncology Treatment Companies Ranked by Revenue (2021) 4.1.2 Global Immuno-Oncology Treatment Revenue by Player (2017-2022) 4.2 Global Immuno-Oncology Treatment Concentration Ratio (CR) 4.2.1 Immuno-Oncology Treatment Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Companies of Immuno-Oncology Treatment in 2021 4.2.3 Global Immuno-Oncology Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Immuno-Oncology Treatment Headquarters, Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Type 4.3.1 Global Immuno-Oncology Treatment Headquarters and Area Served 4.3.2 Global Immuno-Oncology Treatment Companies Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Type 4.3.3 Date of International Companies Enter into Immuno-Oncology Treatment Market 4.4 Companies Mergers & Acquisitions, Expansion Plans 4.5 United States Immuno-Oncology Treatment Market Size by Company 4.5.1 Top Immuno-Oncology Treatment Players in United States, Ranked by Revenue (2021) 4.5.2 United States Immuno-Oncology Treatment Revenue by Players (2020, 2021 & 2022) 5 Global Immuno-Oncology Treatment Market Size by Region 5.1 Global Immuno-Oncology Treatment Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Immuno-Oncology Treatment Market Size by Region (2017-2028) 5.2.1 Global Immuno-Oncology Treatment Market Size by Region: 2017-2022 5.2.2 Global Immuno-Oncology Treatment Market Size by Region (2023-2028) 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Immuno-Oncology Treatment Market Size YoY Growth 2017-2028 6.1.2 North America Immuno-Oncology Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Immuno-Oncology Treatment Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Immuno-Oncology Treatment Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Immuno-Oncology Treatment Market Size YoY Growth 2017-2028 6.3.2 Europe Immuno-Oncology Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Immuno-Oncology Treatment Market Size YoY Growth 2017-2028 6.4.2 Latin America Immuno-Oncology Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Immuno-Oncology Treatment Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Immuno-Oncology Treatment Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Amgen 7.1.1 Amgen Company Details 7.1.2 Amgen Business Overview 7.1.3 Amgen Immuno-Oncology Treatment Introduction 7.1.4 Amgen Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.1.5 Amgen Recent Development 7.2 AstraZeneca 7.2.1 AstraZeneca Company Details 7.2.2 AstraZeneca Business Overview 7.2.3 AstraZeneca Immuno-Oncology Treatment Introduction 7.2.4 AstraZeneca Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.2.5 AstraZeneca Recent Development 7.3 Bristol-Myers Squibb 7.3.1 Bristol-Myers Squibb Company Details 7.3.2 Bristol-Myers Squibb Business Overview 7.3.3 Bristol-Myers Squibb Immuno-Oncology Treatment Introduction 7.3.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.3.5 Bristol-Myers Squibb Recent Development 7.4 Eli-Lilly 7.4.1 Eli-Lilly Company Details 7.4.2 Eli-Lilly Business Overview 7.4.3 Eli-Lilly Immuno-Oncology Treatment Introduction 7.4.4 Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.4.5 Eli-Lilly Recent Development 7.5 Roche 7.5.1 Roche Company Details 7.5.2 Roche Business Overview 7.5.3 Roche Immuno-Oncology Treatment Introduction 7.5.4 Roche Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.5.5 Roche Recent Development 7.6 GlaxoSmithKline 7.6.1 GlaxoSmithKline Company Details 7.6.2 GlaxoSmithKline Business Overview 7.6.3 GlaxoSmithKline Immuno-Oncology Treatment Introduction 7.6.4 GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.6.5 GlaxoSmithKline Recent Development 7.7 Janssen Biotech 7.7.1 Janssen Biotech Company Details 7.7.2 Janssen Biotech Business Overview 7.7.3 Janssen Biotech Immuno-Oncology Treatment Introduction 7.7.4 Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.7.5 Janssen Biotech Recent Development 7.8 Merck 7.8.1 Merck Company Details 7.8.2 Merck Business Overview 7.8.3 Merck Immuno-Oncology Treatment Introduction 7.8.4 Merck Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.8.5 Merck Recent Development 7.9 Novartis 7.9.1 Novartis Company Details 7.9.2 Novartis Business Overview 7.9.3 Novartis Immuno-Oncology Treatment Introduction 7.9.4 Novartis Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.9.5 Novartis Recent Development 7.10 Pfizer 7.10.1 Pfizer Company Details 7.10.2 Pfizer Business Overview 7.10.3 Pfizer Immuno-Oncology Treatment Introduction 7.10.4 Pfizer Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.10.5 Pfizer Recent Development 7.11 Sanofi 7.11.1 Sanofi Company Details 7.11.2 Sanofi Business Overview 7.11.3 Sanofi Immuno-Oncology Treatment Introduction 7.11.4 Sanofi Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.11.5 Sanofi Recent Development 7.12 Spectrum Pharmaceuticals 7.12.1 Spectrum Pharmaceuticals Company Details 7.12.2 Spectrum Pharmaceuticals Business Overview 7.12.3 Spectrum Pharmaceuticals Immuno-Oncology Treatment Introduction 7.12.4 Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.12.5 Spectrum Pharmaceuticals Recent Development 7.13 Takeda 7.13.1 Takeda Company Details 7.13.2 Takeda Business Overview 7.13.3 Takeda Immuno-Oncology Treatment Introduction 7.13.4 Takeda Revenue in Immuno-Oncology Treatment Business (2017-2022) 7.13.5 Takeda Recent Development 8 Research Findings and Conclusion 9 Appendix 9.1 Research Methodology 9.1.1 Methodology/Research Approach 9.1.2 Data Source 9.2 Author Details 9.3 Disclaimer

List of Tables Table 1. Immuno-Oncology Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028) Table 2. Immuno-Oncology Treatment Market Trends Table 3. Immuno-Oncology Treatment Market Drivers Table 4. Immuno-Oncology Treatment Market Challenges Table 5. Immuno-Oncology Treatment Market Restraints Table 6. Global Immuno-Oncology Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Immuno-Oncology Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Immuno-Oncology Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Immuno-Oncology Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Immuno-Oncology Treatment Companies in Global Market, Ranking by Revenue (2021) Table 11. Global Immuno-Oncology Treatment Revenue by Player, (US$ Million), 2017-2022 Table 12. Global Immuno-Oncology Treatment Revenue Share by Player, 2017-2022 Table 13. Global Immuno-Oncology Treatment Companies Market Concentration Ratio (CR5 and HHI) Table 14. Global Immuno-Oncology Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-Oncology Treatment as of 2021) Table 15. Top Players of Immuno-Oncology Treatment in Global Market, Headquarters and Area Served Table 16. Companies Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Type Table 17. Date of International Companies Enter into Immuno-Oncology Treatment Market Table 18. Companies Mergers & Acquisitions, Expansion Plans Table 19. Top Immuno-Oncology Treatment Players in United States Market, Ranking by Revenue (2021) Table 20. United States Immuno-Oncology Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 21. United States Immuno-Oncology Treatment Revenue Share by Players, 2020, 2021 & 2022 Table 22. Global Immuno-Oncology Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 23. Global Immuno-Oncology Treatment Market Size by Region (2017-2022) & (US$ Million) Table 24. Global Immuno-Oncology Treatment Market Size Forecast by Region (2023-2028) & (US$ Million) Table 25. North America Immuno-Oncology Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 26. Asia Pacific Immuno-Oncology Treatment Sales in Value by Region (2017-2028) & (US$ Million) Table 27. Europe Immuno-Oncology Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 28. Latin Americaa Immuno-Oncology Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 29. Middle East and Africa Immuno-Oncology Treatment Sales in Value by Country (2017-2028) & (US$ Million) Table 30. Amgen Company Details Table 31. Amgen Business Overview Table 32. Amgen Immuno-Oncology Treatment Product Table 33. Amgen Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 34. Amgen Recent Development Table 35. AstraZeneca Company Details Table 36. AstraZeneca Business Overview Table 37. AstraZeneca Immuno-Oncology Treatment Product Table 38. AstraZeneca Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 39. AstraZeneca Recent Development Table 40. Bristol-Myers Squibb Company Details Table 41. Bristol-Myers Squibb Business Overview Table 42. Bristol-Myers Squibb Immuno-Oncology Treatment Product Table 43. Bristol-Myers Squibb Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 44. Bristol-Myers Squibb Recent Development Table 45. Eli-Lilly Company Details Table 46. Eli-Lilly Business Overview Table 47. Eli-Lilly Immuno-Oncology Treatment Product Table 48. Eli-Lilly Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 49. Eli-Lilly Recent Development Table 50. Roche Company Details Table 51. Roche Business Overview Table 52. Roche Immuno-Oncology Treatment Product Table 53. Roche Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 54. Roche Recent Development Table 55. GlaxoSmithKline Company Details Table 56. GlaxoSmithKline Business Overview Table 57. GlaxoSmithKline Immuno-Oncology Treatment Product Table 58. GlaxoSmithKline Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 59. GlaxoSmithKline Recent Development Table 60. Janssen Biotech Company Details Table 61. Janssen Biotech Business Overview Table 62. Janssen Biotech Immuno-Oncology Treatment Product Table 63. Janssen Biotech Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 64. Janssen Biotech Recent Development Table 65. Merck Company Details Table 66. Merck Business Overview Table 67. Merck Immuno-Oncology Treatment Product Table 68. Merck Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 69. Merck Recent Development Table 70. Novartis Company Details Table 71. Novartis Business Overview Table 72. Novartis Immuno-Oncology Treatment Product Table 73. Novartis Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 74. Novartis Recent Development Table 75. Pfizer Company Details Table 76. Pfizer Business Overview Table 77. Pfizer Immuno-Oncology Treatment Product Table 78. Pfizer Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 79. Pfizer Recent Development Table 80. Sanofi Company Details Table 81. Sanofi Business Overview Table 82. Sanofi Immuno-Oncology Treatment Product Table 83. Sanofi Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 84. Sanofi Recent Development Table 85. Spectrum Pharmaceuticals Company Details Table 86. Spectrum Pharmaceuticals Business Overview Table 87. Spectrum Pharmaceuticals Immuno-Oncology Treatment Product Table 88. Spectrum Pharmaceuticals Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 89. Spectrum Pharmaceuticals Recent Development Table 90. Takeda Company Details Table 91. Takeda Business Overview Table 92. Takeda Immuno-Oncology Treatment Product Table 93. Takeda Revenue in Immuno-Oncology Treatment Business (2017-2022) & (US$ Million) Table 94. Takeda Recent Development Table 95. Research Programs/Design for This Report Table 96. Key Data Information from Secondary Sources Table 97. Key Data Information from Primary Sources List of Figures Figure 1. Immuno-Oncology Treatment Product Picture Figure 2. Global Immuno-Oncology Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Immuno-Oncology Treatment Market Size 2017-2028 (US$ Million) Figure 4. United States Immuno-Oncology Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028 Figure 5. United States Immuno-Oncology Treatment Market Size 2017-2028 (US$ Million) Figure 6. United States Immuno-Oncology Treatment Market Share in Global 2017-2028 Figure 7. Immuno-Oncology Treatment Report Years Considered Figure 8. Product Picture of Immune Checkpoint Inhibitors Figure 9. Product Picture of Monoclonal Antibodies Figure 10. Product Picture of Cytokine-Based Immunotherapy Figure 11. Product Picture of Cancer Vaccines Figure 12. Product Picture of CAR-T Cell Therapy Figure 13. Global Immuno-Oncology Treatment Market Share by Type in 2022 & 2028 Figure 14. Global Immuno-Oncology Treatment Market Size by Type (2017-2028) & (US$ Million) Figure 15. Global Immuno-Oncology Treatment Market Share by Type (2017-2028) Figure 16. United States Immuno-Oncology Treatment Market Share by Type in 2022 & 2028 Figure 17. United States Immuno-Oncology Treatment Market Size by Type (2017-2028) & (US$ Million) Figure 18. United States Immuno-Oncology Treatment Market Share by Type (2017-2028) Figure 19. Product Picture of Hospitals Figure 20. Product Picture of Ambulatory Surgical Center Figure 21. Product Picture of Others Figure 22. Global Immuno-Oncology Treatment Market Share by Application in 2022 & 2028 Figure 23. Global Immuno-Oncology Treatment Market Size by Application (2017-2028) & (US$ Million) Figure 24. Global Immuno-Oncology Treatment Market Share by Application (2017-2028) Figure 25. United States Immuno-Oncology Treatment Market Share by Application in 2022 & 2028 Figure 26. United States Immuno-Oncology Treatment Market Size by Application (2017-2028) & (US$ Million) Figure 27. United States Immuno-Oncology Treatment Market Share by Application (2017-2028) Figure 28. North America Immuno-Oncology Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 29. U.S. Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 30. Canada Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 31. Europe Immuno-Oncology Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 32. Germany Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 33. France Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 34. U.K. Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 35. Italy Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 36. Russia Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 37. Asia-Pacific Immuno-Oncology Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 38. China Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 39. Japan Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 40. South Korea Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 41. India Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 42. Australia Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 43. Taiwan Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 44. Indonesia Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 45. Thailand Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 46. Malaysia Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 47. Philippines Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 48. Latin America Immuno-Oncology Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 49. Mexico Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 50. Brazil Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 51. Argentina Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 52. Middle East & Africa Immuno-Oncology Treatment Market Size Growth Rate 2017-2028 (US$ Million) Figure 53. Turkey Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 55. U.A.E Immuno-Oncology Treatment Market Size Growth Rate (2017-2028) & (US$ Million) Figure 56. Amgen Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 57. AstraZeneca Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 59. Eli-Lilly Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 60. Roche Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 61. GlaxoSmithKline Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 62. Janssen Biotech Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 63. Merck Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 64. Novartis Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 65. Pfizer Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 66. Sanofi Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 67. Spectrum Pharmaceuticals Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 68. Takeda Revenue Growth Rate in Immuno-Oncology Treatment Business (2017-2022) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Amgen AstraZeneca Bristol-Myers Squibb Eli-Lilly Roche GlaxoSmithKline Janssen Biotech Merck Novartis Pfizer Sanofi Spectrum Pharmaceuticals Takeda